Small Cell Transformation of Metastatic Prostate Adenocarcinoma Diagnosed by Dual-Tracer PET/CT (68Ga-PSMA and 18F-FDG): Potential Clinical Utility in Therapeutic Decision Making and Treatment Monitoring

被引:12
|
作者
Parghane, Rahul
Basu, Sandip [1 ]
机构
[1] Tata Mem Hosp Annexe, Radiat Med Ctr, Jerbai Wadia Rd, Mumbai 400012, Maharashtra, India
关键词
oncology; Lu-177-PSMA therapy; F-18-FDG PET/CT; Ga-68-PSMA PET/CT; penile metastases; small cell carcinoma of prostate;
D O I
10.2967/jnmt.118.215582
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Transformed small cell carcinoma of the prostate represents a tumor biology distinct from its adenocarcinoma counterpart, and penile metastasis from prostate cancer is a rare phenomenon. Biologic heterogeneity among metastatic lesions in a patient with prostatic adenocarcinoma with SCPCa transformation is presented here. The case report shows the significance of using dual-tracer PET/CT with Ga-68-prostate-specific membrane antigen and F-18-FDG in diagnosing small cell carcinoma of prostate transformation in certain lesions, thereby guiding therapeutic strategies. Furthermore, the value of sequential dual-tracer PET/CT in assessing overall disease status, theranostics, and response to multimodality therapy is illustrated.
引用
收藏
页码:85 / 87
页数:3
相关论文
共 50 条
  • [41] The earlier 18F-FDG and 68Ga-DOTA-FAPI-04 dual-tracer total-body PET/CT scan timing: a feasibility study
    Zheng, Z.
    He, Y.
    Mao, W.
    Yu, H.
    Wu, H.
    Hu, P.
    Shi, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S682 - S683
  • [42] Synergic role of dual tracer PET/CT with18F-FDG and68Ga-PSMA in the detection of papillary renal cell carcinoma recurrence
    Gasparro, D.
    Scarlattei, M.
    Manuguerra, R.
    Guglielmo, P.
    Migliari, S.
    Sammartano, A.
    Baldari, G.
    Maestroni, U.
    Ruffini, L.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2022, 41 (05): : 322 - 324
  • [43] Dual-Tracer PET/CT in Non-Small Cell Lung Cancer: A Case Series Analysis Using [18F]FDG and [18F]F-PSMA-1007
    Silveira, N.
    Perroud-Junior, M.
    Ide, H. Nakano
    Amorim, B.
    Lima, M.
    Souza, C.
    Lima, C.
    Ramos, C. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S502 - S503
  • [44] MECF-Net: A prostate cancer lymph node metastasis classification method based on 18F-PSMA-1007 and 18F-FDG dual-tracer PET/CT image feature optimization
    Hao, Junchen
    Cui, Yan
    Jiang, Huiyan
    Tong, Guoyu
    Li, Xuena
    BIOMEDICAL SIGNAL PROCESSING AND CONTROL, 2025, 105
  • [45] Oligometastatic Renal Cell Carcinoma With Sarcomatoid Differentiation Demonstrating Variable Imaging Phenotypes on 68Ga-PSMA and 18F-FDG PET/CT: A Case Report and Review of the Literature
    Nadebaum, David P.
    Hofman, Michael S.
    Mitchell, Catherine A.
    Siva, Shankar
    Hicks, Rodney J.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (01) : 1 - 5
  • [46] Complimentary Pattern of Uptake in 18F-FDG PET/CT and 68Ga-Prostate-Specific Membrane Antigen PET/CT in a Case of Metastatic Clear Cell Renal Carcinoma
    Sasikumar, Arun
    Joy, Ajith
    Nanabala, Raviteja
    Unni, Madhavan
    Padmanabhan, T. K.
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (12) : E517 - E519
  • [47] Machine Learning-Based Noninvasive Quantification of Single-Imaging Session Dual-Tracer 18F-FDG and 68Ga-DOTATATE Dynamic PET-CT in Oncology
    Ding, Wenxiang
    Yu, Jiangyuan
    Zheng, Chaojie
    Fu, Peng
    Huang, Qiu
    Feng, David Dagan
    Yang, Zhi
    Wahl, Richard L.
    Zhou, Yun
    IEEE TRANSACTIONS ON MEDICAL IMAGING, 2022, 41 (02) : 347 - 359
  • [48] Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Patients With Newly Diagnosed Non-Small Cell Lung Cancer
    Wu, Junhao
    Deng, Hao
    Zhong, Haoshu
    Wang, Tao
    Rao, Zijuan
    Wang, Yingwei
    Chen, Yue
    Zhang, Chunyin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] Aggressive Metastatic Insulinoma in a Patient of Diabetes Mellitus with Documentation on Dual-Tracer PET-CT ([68Ga]Ga-DOTATATE and [18F]FDG): Clinical Benefits with Combined Chemo-PRRT Approach
    Edamadaka, Yeshwanth
    Parghane, Rahul V.
    Basu, Sandip
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2024, 23 (04) : 312 - 316
  • [50] Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma
    Has Simsek, Duygu
    Civan, Caner
    Erdem, Selcuk
    Sanli, Yasemin
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (07) : 579 - 581